Search results
4 days ago · At Boehringer Ingelheim we develop breakthrough therapies that improve the lives of both humans and animals. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Now, we are powered by 52,000 employees globally who nurture a diverse, collaborative and inclusive culture.
23 hours ago · Boehringer Ingelheim inaugurated a biomass power plant at its Ingelheim site on Monday. With the new power plant, Boehringer Ingelheim is optimizing its energy supply and protecting the environment at the same time: Around 50,000 tons of CO 2 are saved per year. The CO 2 emissions of the site’s own energy generation are reduced by 70%.
5 days ago · Today Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company (ISIN: FR0012127173; Mnemo: OSE), announced that Boehringer will be progressing their first-in-class SIRPα immuno-oncology program to the next phase in clinical development.
Jun 28, 2024 · Boehringer Ingelheim interview details: 698 interview questions and 662 interview reviews posted anonymously by Boehringer Ingelheim interview candidates.
Jul 1, 2024 · Boehringer and Gubra announce Phase 1 study of BI 3034701, a long-acting, next generation, first-in-class triple agonist peptide for obesity treatment.
Jun 12, 2024 · SEATTLE--(BUSINESS WIRE)-- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, and Boehringer Ingelheim, one of the largest innovators in animal disease prevention and treatment globally, today announced a strategic collaboration to provide pets and their families increased ...
Jun 10, 2024 · With 25 launches planned through 2030, Boehringer Ingelheim is gearing up for a busy few years. As a part of that, the German drugmaker is looking forward to flexing its oncology muscles with...
